Transduction with Cas9 alone led to somewhat lower BAY and Cilo responses as compared to NT controls, which is theoretically possible due to the adenoviral treatment; however, these differences did not reach statistical significance ( Figure 3 D,H).
← all excerpts
CRISPR/Cas9 Knock-Out in Primary Neonatal and Adult Cardiomyocytes Reveals Distinct cAMP Dynamics Regulation by Various PDE2A and PDE3A Isoforms.
1
—
—